SCHEMBL16616667

SCHEMBL16616667

COc1ccc(C(=O)C=Cc2cccnc2Nc2ccc(O)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
RAB9A P51151 3/20 0.54
ALDH1A1 P00352 3/20 0.54
P4HB P07237 1/20 0.54
CALM1 P0DP23 1/20 0.54
F3 P13726 1/20 0.54
XDH P47989 1/20 0.54
NPSR1 Q6W5P4 2/20 0.53
NPC1 O15118 1/20 0.53
HTT P42858 1/20 0.53
TUBB4A P04350 1/20 0.53
TUBB P07437 1/20 0.53
TUBA3C P0DPH7 1/20 0.53
TUBA1B P68363 1/20 0.53
TUBA4A P68366 1/20 0.53
TUBB4B P68371 1/20 0.53
TUBB3 Q13509 1/20 0.53
TUBB2A Q13885 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16616665 1.00 MAPT (0.54) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616863 0.96 ALDH1A1 (0.57) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616864 0.96 ALDH1A1 (0.57) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616527 0.91 ALDH1A1 (0.53) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616529 0.91 ALDH1A1 (0.53) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616620 0.91 MAOB (0.57) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616622 0.91 MAOB (0.57) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616302 0.90 MAOB (0.56) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616546 0.90 MAOB (0.56) MAPTMEN1KMT2ARAB9AALDH1A1
SCHEMBL16616326 0.90 RAB9A (0.61) MAPTMEN1KMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006451-B1 2-anilinonicotinyl based chalcones useful as potential anticancer agents and process for preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-14 US disclosed
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099888-A1 2-Anilinonicotinyl Based Chalcones Useful As Potential Anticancer Agents and Process for Preparation Thereof HCCS, WEE2, WEE1 MAPT 2681/4885MEN1 2511/4885KMT2A 2973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.